NCT00395499View on ClinicalTrials.gov

Measurement of Risperidone and 9-Hydroxyrisperidone in Plasma and Saliva

CompletedOBSERVATIONAL
Enrollment

19

Participants

Timeline

Start Date

May 31, 2001

Study Completion Date

April 30, 2003

Conditions
Patients Already Taking Risperidone for Clinical Indications
Interventions
DRUG

Risperidone

Trial Locations (2)

43210

General Clinical Research Center, Columbus

The Nisonger Center, Columbus

All Listed Sponsors
lead

Ohio State University

OTHER

collaborator

National Institute of Mental Health (NIMH)

NIH

NCT00395499 - Measurement of Risperidone and 9-Hydroxyrisperidone in Plasma and Saliva | Biotech Hunter | Biotech Hunter